Please login to the form below

sepsis

This page shows the latest sepsis news and features for those working in and with pharma, biotech and healthcare.

I want our AI lab to generate cutting-edge technology to diagnose illnesses like sepsis, stroke and heart attacks before symptoms appear,” he added.

Citryll snares €15m backing for its autoimmune disease NETs

In some autoimmune disease such as lupus, vasculitis, pulmonary fibrosis, rheumatoid arthritis and organ damage due to sepsis, it is thought that NETs inadvertently react to host cells, stimulating the release
Takeda’s Alofisel becomes Europe’s first allogeneic stem cell therapy

TiGenix has another adipose-derived product, Cx611, which is currently undergoing a phase I/II trial in severe sepsis.
Takeda offers €520m for stem cell firm TiGenix

as well as additional indications such as sepsis.
CHMP backs Europe’s first allogeneic stem cell therapy

Along with Cx601, TiGenix has another adipose stem cell product (Cx611) in phase II trials for severe sepsis and a cardiac stem cell preparation (AlloCSC-01) heading for phase III in
UK Sepsis Trust named Communiqué charity of the year

Wins praise from the judges for its HCP engagement. The UK Sepsis Trust picked up the Charity, Patient or Professional Association of the Year at last week’s Comm uniqué Awards. ... Since the charity’s formation, mortality rates in the UK have

More from news
Approximately 4 fully matching, plus 31 partially matching documents found.

Leicester NHS Trust’s staff intranet is integral to HCPs’ working day

Clinical education is another well-used section of the intranet; while anything on infection prevention is widely viewed, for example, information on C. difficile, MRSA and sepsis.
30 Women Leaders in UK Healthcare (part 3)

One notable project involved Williams reformulating the active ingredient from a GSK mouthwash, chlorhexidine, into a gel to help prevent neonatal sepsis – thereby turning a similar consumer health product into a
Pharma deals in May 2015

The option is exercisable on completion of the phase II studies in acute kidney injury related to sepsis.
The impending threat of antibiotic resistance

Causes of death by infection in the pre-antibiotic era . Childbirth. 9 women in 1000 die in childbirth - 40% from sepsis. ... Every year 35, 000 people die from sepsis in the UK – some of these deaths are from antibiotic resistant infections.
Detecting and managing NS

Campaign:Increasing awareness of neutropenic sepsis (NS). Timescale:2009 to 2010. The publication of two reports from the National Chemotherapy Advisory Group (NCAG) and the National Confidential Enquiry into Patient Outcome ... the early recognition and

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

TiGenix appoints Dr Marie Paule Richard

In her new role Richard will be responsible for the development of several products in Europe and the US, including rheumatoid arthritis and severe sepsis candidate Cx611 and Cx601, which is

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Account Director - Healthcare Advertising - London - 2 DAYS HOME...: £50000 - £70000

FREELANCE Account Director – Healthcare Advertising – London – 3...: Competitive Daily Rates

Senior Account Executive – Account Manager – Healthcare Advertis...: £32000 - £43000 Bonus Benfits

Senior Account Manager > Account Director - London - Medical ...: Salary TBC

FREELANCE Medical Writer (Initial 2/ 3 months term) - London Off...: Excellent Daily Rate

Account Director – London based Medical Communications Agency: Excellent Remuneration Package

Account Director - Medical Communications - London / South East: Excellent Salary and Benefits on offer

Add my company

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

The relevance of patient perspectives to value: Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?: Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
The evolution of real-world studies: How industry and regulators are using real-world data...